Management of Venous Thromboembolism in Myeloproliferative Neoplasms

Venous thromboembolism is frequent in chronic myeloproliferative neoplasms (MPNs). The current strategy for its management includes cytoreductive therapy and antithrombotic prophylaxis, but many issues remain uncertain. In this review, the risk factors and prevention of recurrences are discussed.

 Curr Opin Hematol

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.